Related Experiment Videos
5-Hydroxytryptamine receptor in rabbit aorta: characterization by butyrophenone analogs
Summary
Spiperone and similar drugs competitively block 5-hydroxytryptamine (5-HT) in rabbit aorta rings. This suggests aortic "D" receptors are similar to brain 5-HT2 binding sites, with drug structure influencing antagonism.
Area of Science:
- Pharmacology
- Neuroscience
- Cardiovascular Research
Background:
- 5-hydroxytryptamine (5-HT) plays a role in vascular contraction.
- Butyrophenone analogs are known to interact with various receptors.
Purpose of the Study:
- To investigate the antagonistic effects of spiperone and related butyrophenones on 5-HT-induced contractions in rabbit aorta.
- To explore the relationship between aortic receptors and brain 5-HT2 binding sites.
Main Methods:
- Isolated rabbit aorta rings were used to measure contractile responses.
- Competitive antagonism assays were performed with spiperone and four analogs.
- Binding affinities (Kd) for [3H]ketanserin and [3H]spiperone in rat brain membranes were compared to aortic inhibition constants (Kb).
Main Results:
- Spiperone and four butyrophenone analogs competitively antagonized 5-HT-induced contractions with nanomolar Kb values.
- The rank order of antagonism was spiperone > spirilene > benperidol > azaperone > haloperidol.
- Aortic receptor inhibition constants (Kb) closely matched brain receptor binding affinities (Kd), suggesting congruence between aortic "D" receptors and brain 5-HT2 sites.
Conclusions:
- Aortic "D" receptors likely correspond to 5-HT2 type binding sites found in the rat brain.
- The non-butyrophenone portion of the antagonist molecules significantly influences their potency in antagonizing 5-HT receptors in the aorta.